Status:
COMPLETED
Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle
Lead Sponsor:
Ain Shams University
Conditions:
Infertility, Female
Eligibility:
FEMALE
20-39 years
Phase:
NA
Brief Summary
The aim of the current study is to compare agonist trigger and HCG luteal support vs standard HCG trigger and progesterone luteal supplementation in antagonist controlled hyperstimulation cycle as reg...
Detailed Description
Prospective Interventional randomized pilotstudy on patients undergoing controlled ovarian hyperstimulation. All patients will receive a fixed dose of 150-300 IU recombinant FSH (Gonal-F; Sereno Labo...
Eligibility Criteria
Inclusion
- Age between 20 and 39 years.
- Body mass index between 18 and 30.
- Unexplained infertility or male factor infertility
Exclusion
- Endocrinological disorder eg.:hyperprolactenemia, Hypo or hyper thyrodism
- More than 2 previous attemptsof IVF
- Any uterine anatomical anomaly.
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04846218
Start Date
December 1 2016
End Date
June 1 2020
Last Update
November 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AinShams Maternity Hospital
Cairo, Egypt, 002